Additive risks of ventilation and renal failure. Benefit of feeding and ranitidine.
| In ventilated critically ill patients, renal failure is
independently associated with an increased rate of clinically significant GI Bleeding. Enteral feeding and ranitidine reduces this risk.
Level of Evidence 2++ |
Citation/s:
Cook DJ et al for The Canadian Clinical Trials Group. Risk Factors for Clinically important upper Gastrointestinal bleeding in patients requiring mechanical ventilation. Critical Care Medicine. 1999;27(12):2812-2817 Lead author's name and fax: Deborah J Cook. McMaster University, Hamilton, Ontario, Canada.
Three-part Clinical Question: What is the incidence of Clinically important Upper BI haemorrhage in ventilated critical care patients. In these patients what are the main risk factors associated with bleeding.
Search Terms: Critical care, ranitidine, sucralfate, RCT, Human, English The Study:
Cohort study. Double blinded, randomised. The Study Patients: 1077 critically ill patients ventilated for at least 48 hours. The patients were sampled from 16 university-affiliated ICUs in Canada. The patient were randomized to receive sucralfate or ranitidine.
Exclusions: admitting diagnosis of GI bleed, pneumonia, gastrectomy, predicted survival of less than 72 hours, more than 2 previous doses of stress ulcer prophylaxis.
Prognostic Factor: APACHE II score, MOD score (Six domains; cardiovascular, pulmonary, renal, hepatic, haematological, CNS. Coagulation data was not collected, therefore its impact on GI bleeding was not examined.
The Outcome: Death. Pneumonia or clinically important bleeding before ICU discharge.
Definition of Gastrointestinal bleeding All patients were monitored for clinical
signs of overt bleeding, including haematemesis, NG aspirate containing blood or
coffee ground material, malena or pr bleeding. Clinically important bleeding was
defined as overt bleeding plus of the following, in the absence of another
cause: (1) a spontaneous drop of 20mmHg or more in the systolic or diastolic
blood pressure within 24hrs of a gastrointestinal haemorrhage, (2) an increase
in the pulse rate of more than 20bpm and an decrease in the SBP of more than
10mmHg on the patient assuming an upright position, (3) a decrease in Hb of a
least 2g/dl in 24hrs and the transfusion of 2 units of packed red cells within
24hrs after bleeding, (4) failure of the Hb conc. to increase after transfusion
by at least the number of units transfused minus 2. There was a well-defined sample at a uniform (early) stage of illness. Follow-up was long enough; follow-up was complete. There were blind, objective outcome criteria. Adjustment was made for other prognostic factors. Can't tell if there was validation in an independent test-set of patients.
The evidence: Univariable regression | Prognostic Factor | Outcome | Result | Measure | Confidence Interval | | Platelet Count < 50,000 | Bleed in ICU | 2.58 | OR | 1.19-5.57 |
|---|
| Maximum MOD score | Bleed in ICU | 1.11 | OR | 1.01 - 1.21 |
|---|
| Renal Domain of MOD score | Bleed in ICU | 1.46 | OR | 1.14 - 1.87 |
|---|
| Pulmonary Domain of MODs | Bleed in ICU | 1.56 | OR | 0.99 - 2.47 |
|---|
| Hepatic Domain of MOD score | Bleed in ICU | 1.37 | OR | 1.04 - 1.77 |
|---|
The Evidence:
Multivariable regression | Prognostic Factor | Outcome | Result | Measure | Confidence Interval | Independent? | | Maximum serum Creatinine |
GI bleed in ICU | 2.58 | OR | 1.16 - 1.32 | yes |
|---|
| Enteral nutrition | GI bleed in ICU | 0.3 | OR | 0.13 - 0.67 | yes |
|---|
| Ranitidine administration | GI bleed in ICU | 0.39 | OR | 0.17 - 0.83 | yes |
Comments:
Sucralfate did not significantly reduce the risk of bleeding. Ranitidine was
superior to sucralfate in unfed, partially fed and fully fed patients. A well
conducted study with a large patient population. Ventilated patients who develop
organ failure are at increase risk of GI bleeding. This is particularly the case
for renal failure. This risk can be reduced by enteral feeding and the
administration of ranitidine. Quite correctly the authors suggest that the
impact of enteral feeding and ranitidine should be compared in a large
randomized controlled trial. Appraised by: Dr Chris Cairns, Spr in Anaesthetics & Intensive Care, Edinburgh Royal Infirmary; Monday, December 23, 2002 Email: Chris.Cairns@btinternet.com Kill or Update By: Dec 2007
Printer-friendly format |